Ziprasidone
- Product NDC
- 62135-994
- 11-digit product format
- 621350994
- Labeler code
- 62135
- Product ID
- 62135-994_02591199-8759-8e40-e063-6294a90afa7f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ziprasidone
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA090348
- Marketing category
- ANDA
- Marketing start
- 2012-09-05
- Substance
- ZIPRASIDONE HYDROCHLORIDE
- Active strength
- 80 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ziprasidone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ZIPRASIDONE HYDROCHLORIDE | 80 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 216X081ORU |
| Rxcui | 313776, 313777, 313778, 314286 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-994-60 | Ziprasidone | 60 in 1 BOTTLE | CAPSULE | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-994 | ZIPRASIDONE CAPSULE ZIPRASIDONE (ZIPRASIDONE) CAPSULE [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20230808_7fbd9460-78a3-4160-9986-3a113de752a6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-994-60 | 62135099460 | 60 CAPSULE in 1 BOTTLE (62135-994-60) | 60 capsule | 2023-04-28 | No | No | Current |